Transforming growth factor‐β1 stimulates macrophage urokinase expression and release of matrix‐bound basic fibroblast growth factor
Data up to Jan 2025
Total Citations Per Year
Abstract
References (72)
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
1988 • 5,115 citations
The Transforming Growth Factor-beta Family
1990 • 3,028 citations
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
1986 • 2,878 citations
Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics
1988 • 1,699 citations
Basement membrane complexes with biological activity
1986 • 1,489 citations
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
1987 • 1,287 citations
The plasminogen activator/plasmin system.
1991 • 1,196 citations
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
1992 • 1,071 citations
Recent developments in the cell biology of basic fibroblast growth factor.
1989 • 1,049 citations
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix.
1987 • 1,045 citations
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
1990 • 992 citations
Molecular architecture of basement membranes
1990 • 937 citations
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism
1989 • 848 citations
Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis
1988 • 845 citations
α-Macroglobulins: structure, shape, and mechanism of proteinase complex formation
1989 • 673 citations
Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis.
1988 • 647 citations
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
1990 • 545 citations
Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds.
1989 • 539 citations
The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
1986 • 466 citations
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
1990 • 466 citations
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.
1986 • 443 citations
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 • 439 citations
Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.
1987 • 434 citations
Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure
1992 • 417 citations
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.
1987 • 378 citations
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.
1989 • 346 citations
TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression
1987 • 344 citations
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
1992 • 336 citations
Binding of plasminogen to cultured human endothelial cells.
1986 • 311 citations
Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesis
1991 • 268 citations
Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture
1991 • 261 citations
Regulation of Type 1 Plasminogen Activator Inhibitor Gene Expression in Cultured Bovine Aortic Endothelial Cells
1989 • 248 citations
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
1987 • 247 citations
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate
1977 • 241 citations
Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.
1989 • 225 citations
Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor
1982 • 225 citations
Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways.
1991 • 219 citations
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.
1990 • 203 citations
Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
1991 • 178 citations
Binding of plasminogen to extracellular matrix.
1986 • 175 citations
Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action.
1990 • 167 citations
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.
1984 • 164 citations
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.
1987 • 158 citations
Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model.
1990 • 138 citations
Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation
1993 • 137 citations
Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells
1991 • 133 citations
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
1990 • 131 citations
Urokinase‐type plasminogen activator and its inhibitor secreted by cultured human monocyte‐macrophages
1985 • 130 citations
Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta
1988 • 118 citations
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.
1991 • 117 citations
Transforming growth factor β alters plasminogen activator activity in human skin fibroblasts
1986 • 114 citations
Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium.
1990 • 112 citations
Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells.
1991 • 111 citations
Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors
1989 • 99 citations
Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.
1988 • 98 citations
Polypeptide Growth Factors in Bone Matrix
2007 • 81 citations
Modulation of monocyte type I transforming growth factor-beta receptors by inflammatory stimuli.
1991 • 72 citations
Involvement of both heparanase and plasminogen activator in lymphoma cell‐mediated degradation of heparan sulfate in the subendothelial extracellular matrix
1986 • 67 citations
Alpha 2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-beta 2 in rat hepatocytes.
1990 • 64 citations
Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin
1990 • 61 citations
Plasminogen activator in synovial fluid from patients with rheumatoid arthritis.
1987 • 55 citations
Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
1991 • 47 citations
Stimulation of macrophage urokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis.
1991 • 42 citations
Binding of transforming growth factor-β1 to methylamine-modified α2-macroglobulin and to binary and ternary α2-macroglobulin-proteinase complexes
1992 • 37 citations
Reaction of α2-macroglobulin with plasmin increases binding of transforming growth factors-β1 and β2
1991 • 36 citations
Inhibition by Methylprednisolone Acetate Suggests an Indirect Mechanism for TGF-B Induced Angiogenesis
1992 • 32 citations
Heparin stimulation of plasminogen activator secretion by macrophage‐like cell line raw264.7: Role of the scavenger receptor
1989 • 28 citations
Increased proteolytic activity on the surface of monocytes from patients with rheumatoid arthritis
1991 • 16 citations
Activation of platelet heparitinase by tumor cell-derived factors
1991 • 13 citations
The effects of the protein kinase C inhibitors staurosporine and H7 on the IgE dependent mediator release from RBL 2H3 cells
1990 • 11 citations
Modulation of plasminogen activators and plasminogen activator inhibitors by TGF-β, IL-1α and EGF in fetal rat caivaria cells at different times of culture
1991 • 10 citations
A selective role for brain histamine in prolactin release induced by opiates
1990 • 5 citations
Cited By (0)
No citing papers found in database